1. Yu MW, Horng IS, Hsu KH, et al. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol. 1999;150(4):367-374.

2. Corraro G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol. 1995;142(11):1136-1146.

3. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginal? Am J Public Health. 1994;84(5):722-724.

4. Alter H, Seef L. Recovery, persistence and sequelae in hepatitis C infection: a perspective on long-term outcome. Sem Liver Disease. 2000;20(1):17-35.

5. Pessione F, Degos F, Marcellin P. Effect of alcohol consumption and serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology. 1998;27(6):1717-1722.

6. Palmer BF. Pathogenesis of ascites and renal salt retention in cirrhosis. J Investig Med. 1999;47(5):183-202.

7. Tandon N, Thakur V, Guptan RK, Sarin SK. Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease. Br J Nutr. 2000;83(3):235-239.